ESCRS - FP15.10 - Long Term Stability And Refractive Outcome Of High Hyperopic Lasik Patients With Customu

Long Term Stability And Refractive Outcome Of High Hyperopic Lasik Patients With Customu

Published 2023 - 41st Congress of the ESCRS

Reference: FP15.10 | Type: Free paper | DOI: 10.82333/yk9d-pq15

Authors: Sara Sella* 1 , David Smadja 2

1Ein-Tal,Tel Aviv,Israel, 2Ophthalmology ,Hadassah Medical Center,Jerusalem ,Israel

Purpose

To present our redractive and abberation outcomes and long term stability of high hyperopic patients how had Custom Q LASIK with FS200/EX500 Alcon

Setting

Retrospective charts review of all patients how had laser vision correction in Ein-Tal Laser institue for correcting high hyperpoia between January 2020 to November 2022 

Methods

This retrospective chart reveiw of consecutive eligible patients with hyperopia of +3D or more undergoing bilteral Laser in situ keratomileusis techniqe was conducted between january 2021 to January 2023. Subanalysis preformed on presbyopic patients on distance/dominant eye. All patient had preoperative and post operative evaluationwhich  includes :Uncorrected visual acuity (UCDVA), Distance Corected Visual Acuity, full menifest refraction and cyclopentolate . corneal tomography with Galilei anf Pentacam with abberation profile. The CutomQ nomogram with our adjusted planning for hyperopic patients was used on all hyperopic patients (Alcon Laboratories, Inc, Fort Worth,TX). post operative visits includes one day, 7 days and,1, 3,6 months.  

Results

Fory five eyes of 45 patients were included. the mean age was 38±5 years (range 18 to 58 years). At six months follow up the spherical equivalent refraction was  +0.25 ± 0.45 diopters. the mean UCDVA biocular vision was o.o1 ± 0.05 logMar. 95% of patients achieved 20/20 or better. High order abberation and corneal asphericty changed significanlty, No correlation between Δ UCDVAto ΔCSA or ΔHOA

Conclusions

Custom Q LASIK for high hyperopic patients is safe and with desirable refractive outcomes